‘Disappointed’ UCB And Amgen Will Appeal CHMP’s Negative Evenity Decision

 
• By Sten Stovall
  
Osteoporosis
CHMP rejection contrasts with FDA's approval of Evenity in April • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip